JOHNS HOPKINS UNIVERSITY
HBV cccDNA transcriptional silencing with and without HIV
HBV cccDNA transcriptional silencing with and without HIV is a funding opportunity from JOHNS HOPKINS UNIVERSITY, up to 818465, closing May 31, 2029.
May 31, 2029
(1035d left)Overview
Hepatitis B virus (HBV) infects 300 million people chronically and is the leading cause of end-stage liver disease and hepatocellular carcinoma (HCC), resulting in ~1 million deaths annually. HIV is a common co- infection in people with chronic hepatitis B (CHB) and worsens HBV and liver disease outcomes. Liver…